B细胞急性淋巴细胞白血病-话题@MedSci

#B细胞急性淋巴细胞白血病#

9篇内容 | 845人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2200897, encodeId=98b6220089ef6, content=<a href='/topic/show?id=18f43131be' target=_blank style='color:#2F92EE;'>#B-ALL#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=ef26384487' target=_blank style='color:#2F92EE;'>#B细胞急性淋巴细胞白血病#</a>, objectTitle=【CII】G-CSF对CAR-T治疗R/R B-ALL的疗效和毒性的影响, objectType=article, longId=823505, objectId=00108235052b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-doctor-review-PTX6YZP.jpg, objectUrl=/article/show_article.do?id=00108235052b, replyNumber=0, likeNumber=10, createdTime=2024-04-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=00108235052b, moduleTitle=【CII】G-CSF对CAR-T治疗R/R B-ALL的疗效和毒性的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00108235052b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1477172, encodeId=404414e71728b, content=<a href='/topic/show?id=ef26384487' target=_blank style='color:#2F92EE;'>#B细胞急性淋巴细胞白血病#</a>, objectTitle=药明巨诺宣布倍诺达®针对儿童及年轻成人复发或难治性B细胞急性淋巴细胞白血病的临床试验申请获批, objectType=article, longId=724745, objectId=639fe24745ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=639fe24745ff, replyNumber=0, likeNumber=40, createdTime=2022-04-23, rootId=0, userName=12498474m32暂无昵称, userId=f3587357279, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=639fe24745ff, moduleTitle=药明巨诺宣布倍诺达®针对儿童及年轻成人复发或难治性B细胞急性淋巴细胞白血病的临床试验申请获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=639fe24745ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477171, encodeId=972114e717141, content=<a href='/topic/show?id=ef26384487' target=_blank style='color:#2F92EE;'>#B细胞急性淋巴细胞白血病#</a>, objectTitle=JAMA：Blinatumomab可提高首次复发的B细胞急性淋巴细胞白血病高危患儿无事件生存率, objectType=article, longId=207858, objectId=4adc20e8585b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4adc20e8585b, replyNumber=0, likeNumber=40, createdTime=2021-03-05, rootId=0, userName=12498474m32暂无昵称, userId=f3587357279, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4adc20e8585b, moduleTitle=JAMA：Blinatumomab可提高首次复发的B细胞急性淋巴细胞白血病高危患儿无事件生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4adc20e8585b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477170, encodeId=334014e71707a, content=<a href='/topic/show?id=ef26384487' target=_blank style='color:#2F92EE;'>#B细胞急性淋巴细胞白血病#</a>, objectTitle=JAMA：Blinatumomab vs 化疗用于首次复发的B细胞急性淋巴细胞白血病儿童、青少年和年轻患者, objectType=article, longId=207857, objectId=663420e857ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=663420e857ae, replyNumber=0, likeNumber=44, createdTime=2021-03-05, rootId=0, userName=12498474m32暂无昵称, userId=f3587357279, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=663420e857ae, moduleTitle=JAMA：Blinatumomab vs 化疗用于首次复发的B细胞急性淋巴细胞白血病儿童、青少年和年轻患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=663420e857ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477169, encodeId=2d9214e7169f6, content=<a href='/topic/show?id=ef26384487' target=_blank style='color:#2F92EE;'>#B细胞急性淋巴细胞白血病#</a>, objectTitle=CAR-T治疗复发B细胞急性淋巴细胞白血病患儿获得完全缓解, objectType=article, longId=195407, objectId=8e5719540e54, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e5719540e54, replyNumber=0, likeNumber=48, createdTime=2020-06-07, rootId=0, userName=12498474m32暂无昵称, userId=f3587357279, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e5719540e54, moduleTitle=CAR-T治疗复发B细胞急性淋巴细胞白血病患儿获得完全缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e5719540e54)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477168, encodeId=ebfe14e716853, content=<a href='/topic/show?id=ef26384487' target=_blank style='color:#2F92EE;'>#B细胞急性淋巴细胞白血病#</a>, objectTitle=中国MNPA批准细胞疗法GC007g治疗CD19阳性复发难治B细胞急性淋巴细胞白血病的IND, objectType=article, longId=191470, objectId=27641914e046, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27641914e046, replyNumber=0, likeNumber=59, createdTime=2020-04-06, rootId=0, userName=12498474m32暂无昵称, userId=f3587357279, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27641914e046, moduleTitle=中国MNPA批准细胞疗法GC007g治疗CD19阳性复发难治B细胞急性淋巴细胞白血病的IND, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27641914e046)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477167, encodeId=777414e7167b9, content=<a href='/topic/show?id=ef26384487' target=_blank style='color:#2F92EE;'>#B细胞急性淋巴细胞白血病#</a>, objectTitle=CLIN CANCER RES：Tisagenlecleucel治疗B细胞急性淋巴细胞白血病的临床药理学, objectType=article, longId=156351, objectId=2df2156351e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2df2156351e6, replyNumber=0, likeNumber=45, createdTime=2018-12-23, rootId=0, userName=12498474m32暂无昵称, userId=f3587357279, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2df2156351e6, moduleTitle=CLIN CANCER RES：Tisagenlecleucel治疗B细胞急性淋巴细胞白血病的临床药理学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2df2156351e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477166, encodeId=fb6214e71667c, content=<a href='/topic/show?id=ef26384487' target=_blank style='color:#2F92EE;'>#B细胞急性淋巴细胞白血病#</a>, objectTitle=NEJM：Kymriahc治疗儿童和青年复发或难治性B细胞急性淋巴细胞白血病, objectType=article, longId=128476, objectId=1e4c1284e6be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e4c1284e6be, replyNumber=0, likeNumber=38, createdTime=2018-02-02, rootId=0, userName=12498474m32暂无昵称, userId=f3587357279, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e4c1284e6be, moduleTitle=NEJM：Kymriahc治疗儿童和青年复发或难治性B细胞急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e4c1284e6be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477165, encodeId=a7a214e716580, content=<a href='/topic/show?id=ef26384487' target=_blank style='color:#2F92EE;'>#B细胞急性淋巴细胞白血病#</a>, objectTitle=STM：通用CAR-T成功治疗2例B细胞急性淋巴细胞白血病, objectType=article, longId=88127, objectId=d4478812e0b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4478812e0b, replyNumber=0, likeNumber=39, createdTime=2017-01-29, rootId=0, userName=12498474m32暂无昵称, userId=f3587357279, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4478812e0b, moduleTitle=STM：通用CAR-T成功治疗2例B细胞急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4478812e0b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477164, encodeId=a70c14e716416, content=<a href='/topic/show?id=ef26384487' target=_blank style='color:#2F92EE;'>#B细胞急性淋巴细胞白血病#</a>, objectTitle=NEJM：利妥昔单抗可延长B细胞急性淋巴细胞白血病患者生存期, objectType=article, longId=77709, objectId=5f4ae770963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f4ae770963, replyNumber=0, likeNumber=40, createdTime=2016-09-19, rootId=0, userName=12498474m32暂无昵称, userId=f3587357279, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f4ae770963, moduleTitle=NEJM：利妥昔单抗可延长B细胞急性淋巴细胞白血病患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f4ae770963)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

B细胞急性淋巴细胞白血病

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#B-ALL# #CAR-T# #B细胞急性淋巴细胞白血病#

【CII】G-CSF对CAR-T治疗R/R B-ALL的疗效和毒性的影响

2024-04-28发表于陕西省

12498474m32暂无昵称 (审核中...)

前往app查看评论内容

#B细胞急性淋巴细胞白血病#

药明巨诺宣布倍诺达®针对儿童及年轻成人复发或难治性B细胞急性淋巴细胞白血病的临床试验申请获批

2022-04-23

12498474m32暂无昵称 (审核中...)

前往app查看评论内容

#B细胞急性淋巴细胞白血病#

JAMA：Blinatumomab可提高首次复发的B细胞急性淋巴细胞白血病高危患儿无事件生存率

2021-03-05

12498474m32暂无昵称 (审核中...)

前往app查看评论内容

#B细胞急性淋巴细胞白血病#

JAMA：Blinatumomab vs 化疗用于首次复发的B细胞急性淋巴细胞白血病儿童、青少年和年轻患者

2021-03-05

12498474m32暂无昵称 (审核中...)

前往app查看评论内容

#B细胞急性淋巴细胞白血病#

CAR-T治疗复发B细胞急性淋巴细胞白血病患儿获得完全缓解

2020-06-07

12498474m32暂无昵称 (审核中...)

前往app查看评论内容

#B细胞急性淋巴细胞白血病#

中国MNPA批准细胞疗法GC007g治疗CD19阳性复发难治B细胞急性淋巴细胞白血病的IND

2020-04-06

12498474m32暂无昵称 (审核中...)

前往app查看评论内容

#B细胞急性淋巴细胞白血病#

CLIN CANCER RES：Tisagenlecleucel治疗B细胞急性淋巴细胞白血病的临床药理学

2018-12-23

12498474m32暂无昵称 (审核中...)

前往app查看评论内容

#B细胞急性淋巴细胞白血病#

NEJM：Kymriahc治疗儿童和青年复发或难治性B细胞急性淋巴细胞白血病

2018-02-02

12498474m32暂无昵称 (审核中...)

前往app查看评论内容

#B细胞急性淋巴细胞白血病#

STM：通用CAR-T成功治疗2例B细胞急性淋巴细胞白血病

2017-01-29

12498474m32暂无昵称 (审核中...)

前往app查看评论内容

#B细胞急性淋巴细胞白血病#

NEJM：利妥昔单抗可延长B细胞急性淋巴细胞白血病患者生存期

2016-09-19

科室
- - 订阅+
  - 更多科室
工具
服务